(51 days)
Not Found
No
The device is a calibrator for in vitro diagnostic tests and the description focuses on its composition, stability, and traceability, with no mention of AI or ML.
No.
The device is an in vitro diagnostic product used for calibrating methods to measure high-density lipoprotein cholesterol (HDLC) and low-density lipoprotein cholesterol (LDLC), not for treating a disease or condition.
Yes
The "Intended Use / Indications for Use" section states that "The LIPID CAL is an in vitro diagnostic product for the calibration of high density lipoprotein cholesterol (HDLC) and low density lipoprotein cholesterol (LDLC) methods on the Dimension Vista™ System," clearly identifying it as an in vitro diagnostic product.
No
The device description explicitly states it is a liquid, multi-analyte, human albumin based product containing human lipoproteins and bovine gamma globulins, provided in vials. This describes a physical, chemical reagent, not software.
Yes, this device is an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The "Intended Use / Indications for Use" section explicitly states that the LIPID CAL is an "in vitro diagnostic product for the calibration of high density lipoprotein cholesterol (HDLC) and low density lipoprotein cholesterol (LDLC) methods on the Dimension Vista™ System." This clearly indicates its use in a laboratory setting to calibrate instruments used for diagnostic testing.
- Device Description: The description details a product used in a laboratory setting ("liquid, multi-analyte, human albumin based product containing human lipoproteins and bovine gamma globulins") and its purpose is for calibration, which is a crucial step in ensuring the accuracy of diagnostic tests.
- Traceability: The "Traceability" section mentions standardization to reference methods (NCEP reference method), which is a common requirement for IVD products to ensure accuracy and comparability of results.
- Predicate Devices: The mention of "Predicate Device(s)" with K numbers (K983850 and K020723) indicates that this device is being compared to previously cleared IVD devices, further supporting its classification as an IVD.
The information provided aligns with the definition and characteristics of an In Vitro Diagnostic device, which is a medical device intended for use in vitro for the examination of specimens derived from the human body solely or principally for the purpose of providing information concerning a physiological or pathological state, or concerning a congenital abnormality, or to monitor therapeutic measures. In this case, the device is used to calibrate instruments that perform such examinations.
N/A
Intended Use / Indications for Use
The LIPID CAL is an in vitro diagnostic product for the calibration of high density lipoprotein cholesterol (HDLC) and low density lipoprotein cholesterol (LDLC) methods on the Dimension Vista™ System.
Product codes
JIX
Device Description
LIPID CAL is a liquid, multi-analyte, human albumin based product containing human lipoproteins and bovine gamma globulins. The kit consists of six vials, three vials of Calibrator A, and three vials of Calibrator B which are ready for use (no preparation is required). The volume per vial is 1.5 mL.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
- Stability: Target shelf life for the Dimension Vista™ Lipid Calibrator is 12 months. Calibrator shelf life is determined by comparing results of the product stored at 4°C with control stored at -20°C. The method is calibrated from this stored material. The 4°C material values are recovered versus the calibration. Recovery versus time is monitored and percent change over time is determined. Percent change should be less than or equal to 3%. Shelf-life stability (expiration) dating assignment at commercialization reflects the real-time data on file at Dade Behring, Inc. A vial punctured by the instrument and stored on board has a seven day claim. An open vial not stored on board of instrument, but recapped and stored in a refrigerator has a stability claim of 30 days. For testing, vials are opened /punctured on day zero. A quantity sufficient for multiple calibrations is removed and the vials are recapped and stored at 2 - 8 °C. Opened/punctured vials are tested on days 8, 15, 22, and 32 versus freshly opened vials.
- Traceability: The assigned values of the Dimension Vista™ Lipid Calibrator are standardized to the enclosed table of assigned values.
- Bottle Value Assignment: Human HDL (bovine based) and LDL (human serum based) are weighed protein containing solutions. The HDL Master Pool and the LDL Anchor Pool are stored at -70 °C. HDL human serum samples with Abel-Kendall values are used to produce a standard curve for the assignment of the Master Pool. LDL human serum pools with values from reference laboratories (CRMNL) are used to produce a standard curve for assignment of the Anchor Pool. The commercial lot is made by adding human HDL and LDL to base matrix in appropriate concentrations for upper calibrator levels. The concentration of each level is verified by using an instrument calibrated with the Master Pool / Anchor Pools. The final bottle values for each level of the commercial lot is assigned and verified using multiple instruments by testing N = 90 replicates.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 862.1150 Calibrator.
(a)
Identification. A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
0
AUG 1 1 2006
510(k) Summary for the Dimension Vista™ System Lipid Calibrator (LIPID CAL - KC220)
A. 510(k) Number:
| B. Analytes: | High density lipoprotein cholesterol (HDLC) and low density
cholesterol lipoprotein (LDLC). |
|------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| C. Type of Test: | Calibrator Material |
| D. Applicant: | Dade Behring Inc., P.O. Box 6101, Newark, DE 19714-6101
Victor M. Carrio, Regulatory Affairs and Compliance Manager
Office: (302) 631-0376 Fax: (302) 631-6299 |
E. Proprietary and Established Names:
Dimension Vista™ System Lipid Calibrator (LIPID CAL - KC220)
F. Regulatory Information:
-
- Regulation section: 21 CFR § 862-1150 Calibrator
-
- Classification: Class II
-
- Product Code: JIX Calibrator, Multi-Analyte Mixture
-
- Panel: Clinical Chemistry
- The LIPID CAL is an in vitro diagnostic product for the calibration G. Intended Use: of high density lipoprotein cholesterol (HDLC) and low density lipoprotein cholesterol (LDLC) methods on the Dimension Vista™ System.
H. Device Description:
LIPID CAL is a liquid, multi-analyte, human albumin based product containing human lipoproteins and bovine gamma globulins. The kit consists of six vials, three vials of Calibrator A, and three vials of Calibrator B which are ready for use (no preparation is required). The volume per vial is 1.5 mL.
1
| Ch Analaman |
|---|
| 31 55 206 7 49 4 9 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 |
| A BAR BAR AND BARRE AN AND |
| CARD F |
| 1000 100 100 100 100 100 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000000000000000000 |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| 1 |
.
| Item | Device | Predicates | Predicates |
|---|---|---|---|
| Dimension Vista™ System | |||
| Lipid Calibrator | Dimension® HDL Calibrator | ||
| K983850 | Dimension® ALDL Calibrator | ||
| K020723 | |||
| Intended Use | The LIPID CAL is an in vitro | ||
| diagnostic product for the calibration | |||
| of high density lipoprotein cholesterol | |||
| (HDLC) and low density lipoprotein | |||
| cholesterol (LDLC) methods on the | |||
| Dimension Vista™ System. | The HDL Cholesterol Calibrator is an in vitro | ||
| diagnostic product to be used to calibrate the | |||
| Dimension® clinical chemistry system for the | |||
| HDL Cholesterol (HDL) method. | The ALDL Calibrator is an in vitro diagnostic | ||
| product intended to be used to calibrate the | |||
| automated LDL (ALDL) method for the | |||
| Dimension® clinical chemistry system. | |||
| Analytes | High density lipoprotein cholesterol | ||
| and low density lipoprotein | |||
| cholesterol. | High density lipoprotein cholesterol. | Low density lipoprotein cholesterol. | |
| Form | Liquid. | Liquid. | Lyophilized. |
| Traceability | National Cholesterol Education | ||
| Program (NCEP) reference method. | NBS SRM 911 a. | NCEP beta-quantification reference method for | |
| LDL-C b. | |||
| Matrix | Human albumin based product | ||
| containing human lipoproteins and | |||
| bovine gamma globulins. | Stabilized aqueous solution containing | ||
| cholesterol. | Lyophilized buffered bovine serum albumin- | ||
| based product supplemented with human low | |||
| density lipoprotein cholesterol. | |||
| Number of | |||
| Levels | Two levels. | Three levels. | Three levels. |
a - NBS-SRM: National Bereau of Standards - Standard Reference Material.
b -- NCEP - National Cholesterol Education Program
- B. EDXA
- C. Optical Microscopy
- D. X-Ray Diffraction
- E. Thermogravimetric Analysis, Differential Scanning Calorimetry
- F. Brunauer-Emmett-Teller (BET) N2 Adsorption
:
2
J. Standard/Guidance Document Referenced:
medical devices
| 1. Guidance: | Guidance for Industry - Abbreviated 510(k) Submissions for In
Vitro Diagnostic Calibrators; Final, 02/22/1999
Guidance for Industry and FDA Staff - Use of Symbols on Labels
and in Labeling of In Vitro Diagnostic Devices Intended for
Professional Use, 11/30/2004 |
|---------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2. Standards: | CEN 13640 Stability testing of In-Vitro Diagnostic Devices
ISO 14971:2000 Medical devices -Application of risk management to |
K. Performance Characteristics:
| 1. Stability: | Target shelf life for the Dimension Vista™ Lipid Calibrator is 12 months. Calibrator shelf life is determined by comparing results of the product stored at 4°C with control stored at -20°C. The method is calibrated from this stored material. The 4°C material values are recovered versus the calibration. Recovery versus time is monitored and percent change over time is determined. Percent change should be less than or equal to 3%. Shelf-life stability (expiration) dating assignment at commercialization reflects the real-time data on file at Dade Behring, Inc. A vial punctured by the instrument and stored on board has a seven day claim. An open vial not stored on board of instrument, but recapped and stored in a refrigerator has a stability claim of 30 days. For testing, vials are opened /punctured on day zero. A quantity sufficient for multiple calibrations is removed and the vials are recapped and stored at 2 - 8 °C. Opened/punctured vials are tested on days 8, 15, 22, and 32 versus freshly opened vials. |
|---|---|
| 2. Traceability: | The assigned values of the Dimension Vista™ Lipid Calibrator are |
| Constituent | Traceability |
|---|---|
| HDLC | National Cholesterol Education Program (NCEP) |
| reference method | |
| LDLC | National Cholesterol Education Program (NCEP) |
| reference method |
standardized to the enclosed table of assigned values:
3
3. Bottle Value Assignment:
Human HDL (bovine based) and LDL (human serum based) are weighed protein containing solutions. The HDL Master Pool and the LDL Anchor Pool are stored at -70 °C.
HDL human serum samples with Abel-Kendall values are used to produce a standard curve for the assignment of the Master Pool. LDL human serum pools with values from reference laboratories (CRMNL) are used to produce a standard curve for assignment of the Anchor Pool.
The commercial lot is made by adding human HDL and LDL to base matrix in appropriate concentrations for upper calibrator levels. The concentration of each level is verified by using an instrument calibrated with the Master Pool / Anchor Pools. The final bottle values for each level of the commercial lot is assigned and verified using multiple instruments by testing N = 90 replicates.
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES . USA" around the perimeter. Inside the circle is an abstract symbol resembling an eagle or bird-like figure.
Public Health Service
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
Mr. Victor M. Carrio RA/QS Compliance Manager Dade Behring, Inc. 500 GBC Dr. PO Box 6101, M/S 514 Newark, DE 19714-6101
AUG 1 1 2006
Re: K061750
Trade/Device Name: Dimension Vista™ Lipid Calibrator (KC220) Regulation Number: 21 CFR§862.1150 Regulation Name: Calibrator Regulatory Class: Class II Product Code: JIX Dated: June 30, 2006 Received: June 21, 2006
Dear Mr. Carrio:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
5
Page 2 -
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Alberto G
Alberto Gutierrez, Ph.D. Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
6
Indications For Use Statement
Kolo 1750 510(k) Number (if known):
Device Name:
Dimension Vista™ Lipid Calibrator (KC220)
Indications for Use:
The LIPID CAL is an in vitro diagnostic product for the calibration of high density lipoprotein cholesterol (HDLC) and low density lipoprotein cholesterol (LDLC) methods on the Dimension Vista™ System.
Prescription Use (Per 21 CFR 801 Subpart D) AND/OR
Over-the-counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of -In Vitro Diagnostic Devices (OIVD)
CFC
K061750